These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 37232808)
1. Intravesical Contrast-Enhanced MRI: A Potential Tool for Bladder Cancer Surveillance and Staging. Tyagi P; Moon CH; Connell M; Ganguly A; Cho KJ; Tarin T; Dhir R; Sholosh B; Maranchie J Curr Oncol; 2023 Apr; 30(5):4632-4647. PubMed ID: 37232808 [TBL] [Abstract][Full Text] [Related]
2. Contrast-enhanced dynamic and diffusion-weighted MR imaging at 3.0T to assess aggressiveness of bladder cancer. Zhou G; Chen X; Zhang J; Zhu J; Zong G; Wang Z Eur J Radiol; 2014 Nov; 83(11):2013-8. PubMed ID: 25213829 [TBL] [Abstract][Full Text] [Related]
3. [Determining the depth of infiltration in urinary bladder carcinoma with contrast medium enhanced dynamic magnetic resonance tomography. With reference to postoperative findings and inflammation]. Venz S; Ilg J; Ebert T; Hierholzer J; Friedrichs R; Hosten N; Felix R Urologe A; 1996 Jul; 35(4):297-304. PubMed ID: 8928358 [TBL] [Abstract][Full Text] [Related]
4. Improving bladder cancer imaging using 3-T functional dynamic contrast-enhanced magnetic resonance imaging. Nguyen HT; Pohar KS; Jia G; Shah ZK; Mortazavi A; Zynger DL; Wei L; Clark D; Yang X; Knopp MV Invest Radiol; 2014 Jun; 49(6):390-5. PubMed ID: 24637583 [TBL] [Abstract][Full Text] [Related]
5. Update on multiparametric MRI of urinary bladder cancer. van der Pol CB; Chung A; Lim C; Gandhi N; Tu W; McInnes MDF; Schieda N J Magn Reson Imaging; 2018 Oct; 48(4):882-896. PubMed ID: 30221801 [TBL] [Abstract][Full Text] [Related]
6. Comparison of magnetic resonance imaging with computed tomography and intravesical ultrasound in staging bladder cancer. Salo JO; Kivisaari L; Lehtonen T Urol Radiol; 1988; 10(4):167-72. PubMed ID: 3072748 [TBL] [Abstract][Full Text] [Related]
7. Multiparametric MRI in differentiation between muscle invasive and non-muscle invasive urinary bladder cancer with vesical imaging reporting and data system (VI-RADS) application. Makboul M; Farghaly S; Abdelkawi IF Br J Radiol; 2019 Dec; 92(1104):20190401. PubMed ID: 31573328 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of gadolinium-diethylenetriaminepentaacetic acid-enhanced magnetic resonance imaging for differentiation between superficial and muscle-invasive tumor of the bladder: a comparative study with computerized tomography and transurethral ultrasonography. Tachibana M; Baba S; Deguchi N; Jitsukawa S; Hata M; Tazaki H; Tanimoto A; Yuasa Y; Hiramatsu K J Urol; 1991 Jun; 145(6):1169-73. PubMed ID: 2033686 [TBL] [Abstract][Full Text] [Related]
9. Dynamic gadolinium-enhanced magnetic resonance imaging in staging of superficial bladder cancer. Scattoni V; Da Pozzo LF; Colombo R; Nava L; Rigatti P; De Cobelli F; Vanzulli A; Del Maschio A J Urol; 1996 May; 155(5):1594-9. PubMed ID: 8627831 [TBL] [Abstract][Full Text] [Related]
10. [Preoperative staging of bladder carcinomas with Gd-DTPA-supported dynamic magnetic resonance tomography. Comparison with plain and Gd-DTPA-supported spin-echo sequences]. Venz S; Hosten N; Ilg J; Mäurer J; Podrabsky P; Fedel M; Ebert T; Nagel R Rofo; 1996 Mar; 164(3):218-25. PubMed ID: 8672777 [TBL] [Abstract][Full Text] [Related]
11. Bladder tumor staging: comparison of contrast-enhanced CT, T1- and T2-weighted MR imaging, dynamic gadolinium-enhanced imaging, and late gadolinium-enhanced imaging. Kim B; Semelka RC; Ascher SM; Chalpin DB; Carroll PR; Hricak H Radiology; 1994 Oct; 193(1):239-45. PubMed ID: 8090898 [TBL] [Abstract][Full Text] [Related]
12. Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a Diagnostic Tool in the Assessment of Tumour Angiogenesis in Urinary Bladder Cancer. Hassanien OA; Abouelkheir RT; Abou El-Ghar MI; Badawy ME; El Gamal SA; El-Hamid MA Can Assoc Radiol J; 2019 Aug; 70(3):254-263. PubMed ID: 30922786 [TBL] [Abstract][Full Text] [Related]
13. [The staging of bladder tumors in MRT: the value of the intravesical application of an iron oxide-containing contrast medium in combination with high-resolution T2-weighted imaging]. Beyersdorff D; Taupitz M; Giessing M; Türk I; Schnorr D; Loening S; Hamm B Rofo; 2000 Jun; 172(6):504-8. PubMed ID: 10916545 [TBL] [Abstract][Full Text] [Related]
15. Gadolinium-enhanced magnetic resonance imaging in the staging of urinary bladder neoplasms. Sohn M; Neuerburg J; Teufl F; Bohndorf K Urol Int; 1990; 45(3):142-7. PubMed ID: 2349758 [TBL] [Abstract][Full Text] [Related]
16. Potential and limitations of diffusion-weighted magnetic resonance imaging in kidney, prostate, and bladder cancer including pelvic lymph node staging: a critical analysis of the literature. Giannarini G; Petralia G; Thoeny HC Eur Urol; 2012 Feb; 61(2):326-40. PubMed ID: 22000497 [TBL] [Abstract][Full Text] [Related]
17. Novel contrast mixture achieves contrast resolution of human bladder wall suitable for T1 mapping: applications in interstitial cystitis and beyond. Tyagi P; Janicki J; Moon CH; Kaufman J; Chermansky C Int Urol Nephrol; 2018 Mar; 50(3):401-409. PubMed ID: 29392488 [TBL] [Abstract][Full Text] [Related]
18. Bladder tumor staging: comparison of conventional and gadolinium-enhanced dynamic MR imaging and CT. Tanimoto A; Yuasa Y; Imai Y; Izutsu M; Hiramatsu K; Tachibana M; Tazaki H Radiology; 1992 Dec; 185(3):741-7. PubMed ID: 1438756 [TBL] [Abstract][Full Text] [Related]
19. Comparison of dynamic contrast-enhanced MRI and dynamic contrast-enhanced CT biomarkers in bladder cancer. Naish JH; McGrath DM; Bains LJ; Passera K; Roberts C; Watson Y; Cheung S; Taylor MB; Logue JP; Buckley DL; Tessier J; Young H; Waterton JC; Parker GJ Magn Reson Med; 2011 Jul; 66(1):219-26. PubMed ID: 21437971 [TBL] [Abstract][Full Text] [Related]